Showing 30 of 3541 posts
Galantas Gold's 2025 results: cash surges to C$13.3M via private placement, strategic JV at Omagh, and new Chile growth option.
JoshuaApril 29, 2026
RHI Magnesita Q1 2026: profit up 15% despite softer demand. Full-year guidance held. Self-help initiatives driving resilience.
JoshuaApril 29, 2026
Aston Martin Q1 2026: gross margin jumps to 34.7% on Valhalla mix, but net debt remains high. Progress yes, but balance sheet risk lingers.
JoshuaApril 29, 2026
Oakley Capital Q1 2026: NAV up 2.7%, but shares fall 18% as discount widens. Portfolio growth vs market sentiment.
JoshuaApril 29, 2026
Arrow Exploration's 2025: production up 13% but profit squeezed by lower prices and impairments; fully funded 2026 drilling and Tapir extension key.
JoshuaApril 29, 2026
Nostrum Oil & Gas FY 2025: resilient cash flow despite production drop. Key positives: processing volumes up, Ural O&G deal extended to 2031. Concern: net debt jumps to $542m.
JoshuaApril 29, 2026
Roadside Real Estate update: DAR acquisition delayed to May 2026 due to CGV funding, but HOCH deal on track with £25m HSBC facility agreed. Key insights for investors.
JoshuaApril 29, 2026
Sovereign Metals' Kasiya DFS delivers US$2.2B NPV, strong economics, but US$727M capex and non-binding offtakes remain key hurdles.
JoshuaApril 29, 2026
Berkeley Energia advances Conchas critical minerals project with promising metallurgy, holds A$64m cash, and pursues $1.25bn arbitration claim against Spain.
JoshuaApril 29, 2026
Sylvania Platinum Q3: production dips but stronger PGM pricing drives 44% revenue jump and 61% EBITDA rise, with cash up 17%.
JoshuaApril 29, 2026
Futura Medical's FY25 results are disappointing with revenue collapse and cash pressure, but a refined strategy and pipeline progress offer a potential path to recovery.
JoshuaApril 29, 2026
Vianet FY26: steady revenue, 88% recurring, net cash and an 85% dividend hike. New CEO appointed. Solid foundations, not explosive growth.
JoshuaApril 29, 2026
PureTech Health 2025 results: leaner strategy, cost cuts, Nasdaq delisting plan, and Celea Phase 3 funding progress.
JoshuaApril 29, 2026
Treatt H1 results in line, profits dip but offer of 305p per share from Döhler now dominates the story.
JoshuaApril 29, 2026
PPHE Hotel Group Q1 results show 8% revenue rise, RevPAR up 4.9%, and smart portfolio moves like New York sale and Waterloo freehold buyback. A steady start to 2026.
JoshuaApril 29, 2026
Electric Guitar secures option on Oklahoma oil & gas assets for its BTM datacentre play – but it’s a high-risk RTO with shares still suspended.
JoshuaApril 29, 2026
Santander UK Q1 profits fall 44% on motor finance provision, but underlying banking steady, costs down, TSB deal nears completion. Resilient quarter with one-off sting.
JoshuaApril 29, 2026
Everyman Media Group reports revenue growth and market share gains, but statutory losses persist. The company pauses expansion in 2026 to optimise existing venues.
JoshuaApril 28, 2026
Howden Joinery posts 3.7% sales growth in early 2026, on track with outlook – a solid, reassuring update for investors.
JoshuaApril 28, 2026
Cake Box FY26 revenue jumps 43% to £61.2m, core business up 12%, profit in line. New stores and digital growth driving momentum.
JoshuaApril 28, 2026
Georgia Capital's 1Q26: flat NAV hides strong private portfolio growth, with Lion Finance Group's FTSE 100 promotion a key catalyst.
JoshuaApril 28, 2026
Pebble Beach Systems delivers strong results: revenue up 7%, profit soars, debt halved, and net cash target set for 2026.
JoshuaApril 28, 2026
Telecom Plus sees record customer growth but FY26 profit at bottom of guidance. New payout policy promises at least 80% payout. Competition and weather weigh.
JoshuaApril 28, 2026
Aquila European Renewables' 2025 NAV drops 29.5% as wind-down gets tougher with asset sales below book values.
JoshuaApril 28, 2026
Tracsis reports improved H1 with 7% revenue growth, stronger margins, and the acquisition of Vesputi to expand digital ticketing in Germany.
JoshuaApril 28, 2026
Symphony Environmental raises FY-2025 revenue guidance, delivers positive Q1 EBITDA, and targets a first-half 2026 net profit.
JoshuaApril 28, 2026
Canal+ Q1 2026: flat revenue, reiterated guidance, and JSE listing on track as MultiChoice turnaround begins.
JoshuaApril 28, 2026
Xeros Technology 2025 results show commercial progress with key partnerships, but losses continue. Laundry, microplastic and denim deals advance.
JoshuaApril 28, 2026
Poolbeg Pharma reports FY25 results with POLB 001 trial progress, cash runway to 2027, and interim data expected this summer.
JoshuaApril 28, 2026